HomeHealthSarepta shares slide again as drugmaker bows to FDA pressure to pause...

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

July 22, 2025

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators

Tags
2

Planned Parenthood wins partial victory in legal fight with Trump administration

I-15 accident sends two young men to hospital

Newstalk 107.9 https://newstalk1079.com

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

For millions in US mobile home parks, clean and safe tap water isn’t a given

The US fertility rate reached a new low in 2024, CDC data shows

US organ donation system faces scrutiny and changes after reports of disturbing near-misses

LEAVE A REPLY Cancel reply

Most Popular

Local reptile rescue hosting interactive event in Pocatello Saturday

Traveling circus make stops in Pocatello, Idaho Falls

Chubbuck boy sets up lemonade stand to raise money for national competition

Jeremy Best to serve life in prison without parole for the deaths of his wife, son, and unborn child

Recent Comments

EDITOR PICKS

Local reptile rescue hosting interactive event in Pocatello Saturday

Traveling circus make stops in Pocatello, Idaho Falls

Chubbuck boy sets up lemonade stand to raise money for national competition

POPULAR POSTS

Local reptile rescue hosting interactive event in Pocatello Saturday

Traveling circus make stops in Pocatello, Idaho Falls

Chubbuck boy sets up lemonade stand to raise money for national competition

POPULAR CATEGORY

ABOUT US

FOLLOW US